A Randomized, Double-Blinded, Placebo-Controlled, Cross Over Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine

INTRODUCTION: Daily oral beta-adrenoreceptor antagonist has been shown to be effective in preventing migraine headaches. Timolol 0.5% ophthalmic solution is a non-selective beta-adrenoreceptor antagonist, where the primary use is for glaucoma. There have been case reports that timolol is effective i...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Dipika, Heim, Andrew J., Bittel, Brennen, Ford, Deetra, Dubinsky, Richard, Gronseth, Gary, Hairston, Vernita, Landazuri, Patrick, Sachen, Fred, Herbelin, Laura, Barohn, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Kansas Medical Center 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106987/
https://www.ncbi.nlm.nih.gov/pubmed/32256967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106987/
https://www.ncbi.nlm.nih.gov/pubmed/32256967

Ejemplares similares